12:00 AM
 | 
Jun 04, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Nicotinic acetylcholine receptor α6 (CHRNA6)

Neurology

INDICATION: Pain

Genetic and mouse studies suggest agonizing CHRNA6 could help treat chronic pain. In 25 strains of mice subjected to mechanical allodynia, genetic sequencing...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >